Price & volume screen · refreshed after the Sep 28, 2026 close
New highs: Healthcare
Stocks that closed at their highest level of the trailing year. A close above every other close in the trailing window. Stocks making new highs have no overhead supply from buyers waiting to break even, which is why many momentum approaches start here.
| # | Company | Price | Today | 1M | 6M | Mkt cap |
|---|---|---|---|---|---|---|
| 1 | ABBVABBVIEHealthcare | $266.28 | +0.73% | +3.1% | +27.2% | $470.55B |
| 2 | AAgilent TechnologiesHealthcare | $175.21 | +1.40% | +11.1% | +58.9% | $49.40B |
| 3 | WATWatersHealthcare | $442.94 | +2.17% | +5.1% | +53.2% | $43.52B |
| 4 | BIIBBiogenHealthcare | $228.69 | +0.48% | +3.2% | +24.4% | $33.79B |
| 5 | MTDMettler-Toledo InternationalHealthcare | $1,545.26 | +2.22% | +9.8% | +25.4% | $30.96B |
| 6 | VTRSViatrisHealthcare | $18.27 | +2.47% | +8.2% | +40.0% | $20.98B |
| 7 | TXG10x GenomicsHealthcare | $88.50 | +3.26% | +36.5% | +354.3% | $11.53B |
| 8 | RGENRepligenHealthcare | $194.09 | +2.33% | +6.6% | +76.3% | $10.95B |
| 9 | AMRXAmneal PharmaceuticalsHealthcare | $20.50 | +3.69% | +13.8% | +73.0% | $7.14B |
| 10 | GRALGRAILHealthcare | $132.63 | +4.52% | +60.8% | +173.5% | $5.92B |
| 11 | KODKodiak SciencesHealthcare | $89.92 | +177.96% | +129.9% | +143.0% | $5.65B |
| 12 | ABCLAbCellera BiologicsHealthcare | $13.92 | +9.61% | +12.3% | +325.7% | $4.51B |
| 13 | CDNACareDxHealthcare | $64.60 | +1.44% | +23.4% | +285.0% | $3.34B |
| 14 | IMAXImaxHealthcare | $56.13 | +0.14% | +8.1% | +53.6% | $3.08B |
| 15 | BLFSBioLife SolutionsHealthcare | $39.15 | +1.71% | +5.2% | +110.6% | $1.92B |
| 16 | SGHTSight SciencesHealthcare | $9.27 | +3.81% | +10.2% | +138.9% | $510.7M |
| 17 | PBYIPUMA BIOTECHNOLOGYHealthcare | $9.82 | +0.51% | +6.3% | +61.5% | $506.9M |
| 18 | MASS908 DevicesHealthcare | $11.66 | +1.92% | +5.0% | +101.7% | $482.0M |
| 19 | AGENAgenusHealthcare | $9.43 | +10.42% | +20.7% | +178.2% | $425.9M |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.